Medical SafetyIbogaine does not treat benzodiazepine withdrawal, and stopping Xanax, Klonopin or Valium suddenly can cause seizures. Why benzodiazepines need a gradual taper first, and how people who also use opioids can be treated safely.
NeuroscienceA 2026 case report described improvements in one woman with Parkinson's after 80 days of low-dose ibogaine. What the case found, the GDNF theory behind it, what is still unknown and the specific risks for people with Parkinson's.
Medical SafetyPeople ask whether ibogaine can help with bulimia, anorexia or binge eating. There are no clinical studies, and eating disorders can raise ibogaine's cardiac risk. An honest guide to the evidence and to safer options.
Medical SafetyMany people search for ibogaine to quit meth, but there are almost no human studies. What is known, the specific risks of methamphetamine for the heart and mind, and which treatments have the best evidence.
Patient GuideIbogaine has been studied for cocaine craving in animals and in open-label human series. What the evidence shows, why cocaine raises the cardiac stakes and what must happen before treatment.
Medical SafetyIbogaine is being studied for alcohol use disorder, but it does not treat alcohol withdrawal and combining the two can be dangerous. What the research shows and how a safe protocol works.
NeuroscienceLarge drops in depression and anxiety have been measured after ibogaine, mostly in veterans and people treated for addiction. What the studies show, why there are no trials for depression alone yet, and the medication risks to know.
Patient GuideOpioid dependence is the condition where ibogaine has the most research. A clear summary of the studies on heroin, painkillers and withdrawal, success and relapse rates, safety and what makes results last.
Medical SafetyFentanyl changes how ibogaine treatment must be done. Why a transition period is needed first, what the research shows for opioid withdrawal, the specific risks and what a safe medical protocol looks like.
NeuroscienceStanford researchers reported that veterans with traumatic brain injury improved in disability, memory, concentration and mood after ibogaine. A plain-language look at the brain findings, the limits of the evidence and the safety questions.
NeuroscienceIn a Stanford study of 30 special operations veterans treated in Mexico, PTSD symptoms fell by 88% one month after ibogaine. Here is what the research shows, its limits, who may be a candidate and how treatment works.
Patient GuideWhat ibogaine treatment in Mexico really costs, what should be included in the price, why the cheapest option can be the most dangerous, and the questions to ask before you pay a deposit.
Patient GuideA clear, evidence-based introduction to ibogaine: where it comes from, how it acts on the brain, what research shows for opioid addiction and PTSD, its real cardiac risks and where it is legal.
NeuroscienceA balanced comparison of ibogaine and maintenance medications for opioid use disorder: how each works, what the evidence shows, the risks, and how patients on methadone, Suboxone or fentanyl are prepared for ibogaine.
Success StoriesTIME's investigation into ibogaine told the story of Navy SEAL Marcus Capone and called the drug both promising and perilous. Here is what the article said, what research has found since, and what it means for patients.
Patient GuideA day-by-day guide to our 7-day medical ibogaine program in Cancun, from screening and arrival to the monitored session, recovery, integration and your 90-day aftercare plan, plus how to prepare and what to pack.
NeuroscienceHow the liver turns ibogaine into noribogaine, why this long-acting metabolite may explain reduced cravings and better mood in the weeks after treatment, and what science has and has not proven yet.
Medical SafetyAn honest look at ibogaine side effects, from nausea and ataxia to QT prolongation and arrhythmia, who should not take it, and the screening and cardiac monitoring that make treatment as safe as possible.